Characterizing the Mechanism of Doxorubicin Mediated SAT1 Induction in Triple-Negative Breast Cancer

被引：0
|
作者：
White, Chloe [1 ]
Liang, Caroline [1 ]
Velenosi, Thomas [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC, Canada
来源：
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2024年 / 102卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：37
相关论文
共 50 条
  • [1] Characterizing the mechanism of doxorubicin-mediated SAT1 induction in breast cancer
    Liang, Caroline
    White, Chloe
    Velenosi, Thomas
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2024, 102 (04) : 3 - 4
  • [2] Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple-Negative Breast Cancer
    Tian, Wenwen
    Zhu, Lewei
    Luo, Yongzhou
    Tang, Yuhui
    Tan, Qingjian
    Zou, Yutian
    Chen, Kun
    Deng, Xinpei
    Tang, Hailin
    Li, Hongsheng
    Cai, Manbo
    Xie, Xiaoming
    Ye, Feng
    ADVANCED SCIENCE, 2024, 11 (36)
  • [3] Characterizing triple-negative breast cancer tumors
    Sam Aparicio
    Genome Biology, 12 (Suppl 1)
  • [4] MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression
    Deng, Ling
    Liao, Li
    Zhang, Yin-Ling
    Hu, Shu-Yuan
    Yang, Shao-Ying
    Ma, Xiao-Yan
    Huang, Min-Ying
    Zhang, Fang-Lin
    Li, Da-Qiang
    CANCER LETTERS, 2023, 560
  • [5] HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
    Wei, Lanjing
    Kim, Sung Hae
    Armaly, Ahlam M.
    Aube, Jeffrey
    Xu, Liang
    Wu, Xiaoqing
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [6] Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin
    Xia Zhang
    Weijun Bai
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 655 - 659
  • [7] Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin
    Zhang, Xia
    Bai, Weijun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (03) : 655 - 659
  • [8] Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer
    Bawaneh, Alaa
    Wilson, Adam S.
    Levi, Nicole
    Howard-McNatt, Marissa M.
    Chiba, Akiko
    Soto-Pantoja, David R.
    Cook, Katherine L.
    CANCERS, 2022, 14 (19)
  • [9] Characterizing the gut microbiome of patients with triple-negative breast cancer.
    Swoboda, April T.
    Sharma, Anukriti
    Olopade, Olufunmilayo I.
    Nanda, Rita
    Gilbert, Jack
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Triple-Negative Breast Cancer
    Winkeljohn, Debra L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (06) : 861 - 863
12345